How are Blast percentages determined? | Discovery Life Sciences

Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments NEW Video - Advancing Oligo Therapeutics: Gene Knockdown Studies in Human Hepatocytes

Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments NEW Video - Advancing Oligo Therapeutics: Gene Knockdown Studies in Human Hepatocytes

Discovery BMMCs provide post-thaw blast (CD45lo) and plasma cell (CD138+CD38+) counts via flow cytometry. Additionally, blast percentages are taken from the diagnostic Bone Marrow report obtained from the patient’s electronic medical record.

Privacy Settings